An important finding in our study was the decreased phosphorylation of JAK2/STAT3 after NBD combined with FMT treatment, thus suggesting that inhibition of the JAK/STAT pathway might be involved in the anti-colitis effect of combination therapy. The gene discussed is STAT3; the disease is colitis.